Home
About Us
Overview
Business Model
Milestones
Our Presence
Board of Directors
Mission, Vision and Values
Environment
Products
Research & Development
Product Development
R & D Capabilities
Infrastructure
Capacities and Capabilities
Regulatory Approvals
Investor Relations
Overview
Financial Highlights
Annual Report
Code of Conduct
Shareholding Pattern
Recent News
Contact Us
Sales Offices
Enquiry Form
FAQs
Infrastructure
Capacities & Capabilities
Gagillapur
Jeedimetla
Bonthapally
Wuhan
Regulatory Approvals
Ibuprofen Facility in Wuhan
Dedicated Ibuprofen Facility
4800 MTPA
Approved by the U.S. FDA, EDQM, TGA, Russian Authority, and MCC Regulatory Authorities